IRADIMED CORPORATION
DE ˙ DB ˙ US46266A1097
76,50 € ↓ -1,50 (-1,92%)
2026-06-03
DEL PRIS
SecurityDE:46K / IRADIMED CORPORATION
InstitutionState Street Corp
Latest Disclosed Ownership204,528 shares
Latest Disclosed Value $ 19,687,865
State Street Corp reports 6.00% increase in ownership of 46K / IRADIMED CORPORATION

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 204,528 shares of IRADIMED CORPORATION (DE:46K) valued at $16,669,032 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 192,952 shares of IRADIMED CORPORATION. This represents a change in shares of 6.00% during the quarter. The current value of the position is $15,646,392 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IRADIMED COM 46266A109 204,528 11,576 6.00 19,688 4.89 0.0007
2026-02-13 2025-12-31 13F IRADIMED COM 46266A109 192,952 5,713 3.05 18,770 40.88 0.0006
2025-11-14 2025-09-30 13F IRADIMED COM 46266A109 187,239 9,850 5.55 13,324 25.62 0.0005
2025-08-14 2025-06-30 13F IRADIMED COM 46266A109 177,389 1,707 0.97 10,606 15.05 0.0004
2025-05-15 2025-03-31 13F IRADIMED COM 46266A109 175,682 1,244 0.71 9,220 -3.91 0.0004
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 174,438 8,905 5.38 9,594 15.26 0.0004
2024-11-14 2024-09-30 13F IRADIMED COM 46266A109 165,533 -3,383 -2.00 8,325 12.15 0.0003
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 168,916 12,942 8.30 7,422 8.18 0.0003
2024-05-15 2024-03-31 13F IRADIMED COM 46266A109 155,974 6,237 4.17 6,861 -4.72 0.0003
2024-02-14 2023-12-31 13F IRADIMED COM 46266A109 149,737 15,273 11.36 7,201 20.70 0.0004
2023-11-14 2023-09-30 13F IRADIMED COM 46266A109 134,464 3,000 2.28 5,966 -4.94 0.0003
2023-08-14 2023-06-30 13F IRADIMED COM 46266A109 131,464 7,183 5.78 6,276 28.34 0.0003
2023-05-15 2023-03-31 13F IRADIMED COM 46266A109 124,281 2,870 2.36 4,890 42.40 0.0003
2023-05-15 2022-12-31 13F/A-99 IRADIMED COM 46266A109 121,411 521 0.43 3,435 -5.50 0.0002
2023-05-15 2022-12-31 13F IRADIMED COM 46266A109 121,411 521 3,435 0.0002
2022-11-15 2022-09-30 13F IRADIMED COM 46266A109 120,890 799 0.67 3,634 -10.84 0.0002
2022-08-15 2022-06-30 13F IRADIMED COM 46266A109 120,091 6,639 5.85 4,076 -19.87 0.0002
2022-05-16 2022-03-31 13F IRADIMED COM 46266A109 113,452 10,950 10.68 5,087 7.39 0.0003
2022-02-14 2021-12-31 13F IRADIMED COM 46266A109 102,502 3,014 3.03 4,737 41.74 0.0002
2021-11-15 2021-09-30 13F IRADIMED COM 46266A109 99,488 3,050 3.16 3,342 17.84 0.0002
2021-08-16 2021-06-30 13F IRADIMED COM 46266A109 96,438 4,993 5.46 2,836 20.32 0.0001
2021-07-09 2021-03-31 13F/A-1 IRADIMED COM 46266A109 91,445 -1,949 -2.09 2,357 10.71 0.0001
2021-05-17 2021-03-31 13F IRADIMED COM 46266A109 91,445 -1,949 2,357 0.0001
2021-02-16 2020-12-31 13F IRADIMED COM 46266A109 93,394 6,636 7.65 2,129 14.77 0.0001
2020-11-10 2020-09-30 13F IRADIMED COM 46266A109 86,758 13,976 19.20 1,855 9.83 0.0001
2020-08-14 2020-06-30 13F IRADIMED COM 46266A109 72,782 6,586 9.95 1,689 19.53 0.0001
2020-06-19 2020-03-31 13F/A-1 IRADIMED COM 46266A109 66,196 1,301 2.00 1,413 -6.86 0.0001
2020-05-11 2020-03-31 13F IRADIMED COM 46266A109 66,196 1,301 1,413 124.0899
2020-02-06 2019-12-31 13F IRADIMED COM 46266A109 64,895 7,357 12.79 1,517 25.48 0.0001
2019-11-14 2019-09-30 13F IRADIMED COM 46266A109 57,538 2,136 3.86 1,209 6.71 0.0001
2019-08-14 2019-06-30 13F IRADIMED COM 46266A109 55,402 720 1.32 1,133 -26.24 0.0001
2019-05-15 2019-03-31 13F IRADIMED COM 46266A109 54,682 -5,403 -8.99 1,536 4.49 0.0001
2019-02-12 2018-12-31 13F IRADIMED COM 46266A109 60,085 3,098 5.44 1,470 -30.59 0.0001
2018-11-09 2018-09-30 13F IRADIMED Common equity shares 46266A109 56,987 24,369 74.71 2,118 212.85 0.0002
2018-08-14 2018-06-30 13F IRADIMED Common equity shares 46266A109 32,618 32,618 677 0.0001
2017-08-14 2017-06-30 13F IRADIMED Common equity shares 46266A109 0 -67,001 -100.00 0 -100.00
2017-05-15 2017-03-31 13F IRADIMED Common equity shares 46266A109 67,001 22,700 51.24 595 20.93 0.0001
2017-02-09 2016-12-31 13F IRADIMED Common equity shares 46266A109 44,301 326 0.74 492 -34.14 0.0000
2017-01-13 2016-09-30 13F/A-1 IRADIMED Common equity shares 46266A109 43,975 1,893 4.50 747 -18.54 0.0001
2016-11-14 2016-09-30 13F IRADIMED Common equity shares 46266A109 43,975 747
2016-08-12 2016-06-30 13F IRADIMED Common equity shares 46266A109 42,082 10,609 33.71 917 52.07 0.0001
2016-05-20 2016-03-31 13F/A-1 IRADIMED Common equity shares 46266A109 31,473 4,900 18.44 603 -18.95 0.0001
2016-05-12 2016-03-31 13F IRADIMED Common equity shares 46266A109 31,473 603
2016-02-16 2015-12-31 13F IRADIMED Common equity shares 46266A109 26,573 8,260 45.10 744 67.19 0.0001
2015-11-16 2015-09-30 13F IRADIMED Common equity shares 46266A109 18,313 5,084 38.43 445 44.48 0.0001
2015-08-13 2015-06-30 13F IRADIMED Common equity shares 46266A109 13,229 13,229 308 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.